The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in BioNTech (BNTX). While the effectiveness of this highly sought-after metric is questionable, the ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...

Problems anticipated as jabs developed more quickly and with less extensive clinical trials than the norm ...

The Trump administration had an opportunity to spark a resurgence in American innovation through intellectual property reform ...

Today in History for Jan. 29: ...

Ipsen Biopharmaceuticals must face a former patient safety employee’s religious bias claims over her alleged firing for ...

Adriel Chen and Devi Sridhar discuss the outbreak of Paediatric Inflammatory Multisystem Syndrome in 2020 and consider what lessons we can learn In mid-March 2020 and into April 2020, paediatric wards ...

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area, has announced it is acquiring privately held ValenzaBio – which ...

Daily Podcasts & Video News – Keep up-to-date with the Thaiger while at work or on-the-go by listening in to the daily briefing. Featuring Thaiger’s own Good Morning Thailand and Thailand News Today ...

Arbutus Biopharma Corporation (NASDAQ: ABUS) has unveiled its strategic objectives for 2025 alongside an encouraging ...